Armata Pharmaceuticals (ARMP) Shares Outstanding (2013 - 2026)

Armata Pharmaceuticals has reported Shares Outstanding (Entity) for 14 years, with the latest figure at $36.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1.25% year-over-year to $36.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.6 million (up 1.25% YoY) and the FY2025 annual result came in at $36.4 million, up 0.69% from the prior year.
• Shares Outstanding (Entity) climbed to $36.6 million in Q1 2026 per ARMP's latest filing, from $36.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $36.6 million in Q1 2026 and troughed at $29.0 million in Q1 2022.
• A 5-year average of $35.8 million and a median of $36.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) soared 44.87% in 2022, then declined 0.06% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $36.1 million in 2022, then slipped by 0.06% to $36.1 million in 2023, then rose by 0.17% to $36.2 million in 2024, then rose by 0.69% to $36.4 million in 2025, then increased by 0.59% to $36.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $36.6 million, $36.4 million, and $36.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.